Thanks to its high specificity, fluoroethyl-tyrosine (FET)-PET can help confirm the success of surgical procedures performed on pediatric patients with brain and spinal cord tumors to ensure that no residual tumor is left behind, according to a study published online January 25 in the Journal of Nuclear Medicine. {read more here}